Clinical trial · Interventional
Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining
Different Lugol's Solution Concentration for Image Quality of Early Esophageal Squamous Neoplasia in Chromoendoscopy With Iodine Staining
NCT03180970CI-TRIAL-00028034unknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to assess whether lower Lugol's solution concentration can perceive the same image quality of early esophageal squamous neoplasia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endoscopists'Subjective Assessments | — | UNRESOLVED | — |
| Image Quality of Early Esophageal Squamous Neoplasia | — | UNRESOLVED | — |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 0.4% Lugol's solution | Drug | — | UNRESOLVED |
| 0.6% Lugol's solution | Drug | — | UNRESOLVED |
| 0.8% Lugol's solution | Drug | — | UNRESOLVED |
| 1.0% Lugol's solution | Drug | — | UNRESOLVED |
| 1.2% Lugol's solution | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- type
- EXPERIMENTAL
- label
- group 1
- description
- This group patients were given dosages of 1.2% Lugol's solution for chromoendoscopy.
- interventionNames
- Drug: 1.2% Lugol's solution
- type
- EXPERIMENTAL
- label
- group 2
- description
- This group patients were given dosages of 1.0% Lugol's solution for chromoendoscopy.
- interventionNames
- Drug: 1.0% Lugol's solution
- type
- EXPERIMENTAL
- label
- group 3
- description
- This group patients were given dosages of 0.8% Lugol's solution for chromoendoscopy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: Patients with early esophageal squamous neoplasia who underwent endoscopic submucosal dissection. Exclusion Criteria: After esophageal surgery or endoscopic treatment ; Known esophageal radiotherapy or chemotherapy ; Esophageal stenosis; Acute bleeding; A known allergy to iodine; Coagulopathy (prothrombin time \<50% of control, partial thromboplastin time \>50 seconds); Having food retention; Severe hepatic ,renal, cardiovascular or metabolic dysfunction ; Being pregnant or lactating.
References
Publications (0)
Data not yet available
No reference posted for this study.